- Report
- April 2024
- 97 Pages
Asia Pacific
From €2825EUR$2,950USD£2,406GBP
- Report
- April 2024
- 100 Pages
Europe
From €2825EUR$2,950USD£2,406GBP
- Report
- March 2021
- 207 Pages
Global
From €4596EUR$4,799USD£3,914GBP
- Report
- May 2023
- 123 Pages
Global
From €5699EUR$5,950USD£4,853GBP
- Report
- July 2023
- 136 Pages
China
From €1724EUR$1,800USD£1,468GBP
- Report
- August 2023
- 77 Pages
Egypt
From €3352EUR$3,500USD£2,855GBP
- Report
- March 2023
- 115 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- July 2022
- 100 Pages
Global
From €2634EUR$2,750USD£2,243GBP
- Report
- December 2022
- 154 Pages
Global
From €2394EUR$2,500USD£2,039GBP
- Report
- August 2022
- 120 Pages
Global
From €2394EUR$2,500USD£2,039GBP
- Clinical Trials
- July 2021
- 90 Pages
Global
From €2394EUR$2,500USD£2,039GBP
- Report
- April 2023
- 113 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- April 2023
- 112 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- April 2023
- 117 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- April 2023
- 115 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- August 2022
- 116 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- May 2021
- 120 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- June 2021
- 38 Pages
Global
€1262EUR$1,318USD£1,075GBP
- Report
- May 2021
- 97 Pages
Global
€21071EUR$22,000USD£17,944GBP
- Report
- May 2021
- 97 Pages
Global
€21071EUR$22,000USD£17,944GBP
Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections.
The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings.
Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more